Clinical Trials

Michel Hermans's picture

By Michel H.E. Hermans, MD

In the first part of this series on the challenges of conducting clinical trials in wound care, I discussed factors that include patient populations and lesion prevalence. Additional criteria and conditions of the clinical trial will be further examined in this blog.

Michel Hermans's picture

By Michel H.E. Hermans, MD

To do a Randomized Controlled Trial within a reasonable time frame, the disease to be studied should be common and the patient population large and accessible. In addition, preferably the effect of the treatment should be fast and specific.

Blog Category: 
Glenda Motta's picture

By Glenda Motta RN, MPH

Coverage and payment for new wound care technology is never automatic, and demands skillful assessment of what various payers require to accept a new treatment modality. Reimbursement is complex and involves coding, coverage, and payment. Too many companies erroneously believe that “getting a code” guarantees payment. Nothing could be further from the truth!

Blog Category: